GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.
Follow GDRX
GoodRx Holdings, Inc. (GDRX) Altman Z-score
GoodRx Holdings, Inc.'s Altman Z-score for fiscal 2025 is 0.44, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 0.44 | (0.92) |
| FY2024 | 1.36 | (0.33) |
| FY2023 | 1.69 | 0.38 |
| FY2022 | 1.31 | (9.06) |
| FY2021 | 10.37 | 2.34 |
| FY2020 | 8.03 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.28 | — | 0.34 | |
| Retained earnings / total assets | (1.00) | — | −1.41 | |
| EBIT / total assets | 0.06 | — | 0.21 | |
| Market value of equity / total liabilities | 1.23 | — | 0.74 | |
| Sales / total assets | 0.57 | — | 0.57 | |
| Altman Z-score | Distress zone | 0.44 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −0.18 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| OMDA Omada Health, Inc. compare | 4.0× |
| HSTM HealthStream, Inc. compare | 3.5× |
| OMCL Omnicell, Inc. compare | 2.7× |
| CERT Certara, Inc. compare | 2.0× |
| MDRX Veradigm Inc. compare | 1.6× |
| SDGR Schrodinger, Inc. compare | 1.1× |
| PHR Phreesia, Inc. compare | 0.7× |
| GDRX GoodRx Holdings, Inc. | 0.4× |
| TDOC Teladoc Health, Inc. compare | −6.7× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets